These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18606662)

  • 1. Epidermal receptor activator of NF-kappaB ligand controls Langerhans cells numbers and proliferation.
    Barbaroux JB; Beleut M; Brisken C; Mueller CG; Groves RW
    J Immunol; 2008 Jul; 181(2):1103-8. PubMed ID: 18606662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous RANK-RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans Cell Apoptosis.
    Klenner L; Hafezi W; Clausen BE; Lorentzen EU; Luger TA; Beissert S; Kühn JE; Loser K
    J Invest Dermatol; 2015 Nov; 135(11):2676-2687. PubMed ID: 26076314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
    J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit.
    Duheron V; Hess E; Duval M; Decossas M; Castaneda B; Klöpper JE; Amoasii L; Barbaroux JB; Williams IR; Yagita H; Penninger J; Choi Y; Lézot F; Groves R; Paus R; Mueller CG
    Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5342-7. PubMed ID: 21402940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of erythromycin on RANKL and nuclear factor-kappa B by human TNF-alpha stimulated Jurkat cells.
    Wu L; Lin JH; Bao K; Li PF; Zhang WG
    Int Immunopharmacol; 2009 Aug; 9(9):1105-9. PubMed ID: 19500694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget disease by receptor activator of nuclear factor kappa B (RANK) ligand/RANK pathways.
    Fujimura T; Kambayashi Y; Furudate S; Kakizaki A; Hidaka T; Aiba S
    Br J Dermatol; 2017 Feb; 176(2):387-394. PubMed ID: 27411503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells.
    Loser K; Mehling A; Loeser S; Apelt J; Kuhn A; Grabbe S; Schwarz T; Penninger JM; Beissert S
    Nat Med; 2006 Dec; 12(12):1372-9. PubMed ID: 17143276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
    J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.
    Totsuka T; Kanai T; Nemoto Y; Tomita T; Okamoto R; Tsuchiya K; Nakamura T; Sakamoto N; Akiba H; Okumura K; Yagita H; Watanabe M
    J Immunol; 2009 May; 182(10):6079-87. PubMed ID: 19414759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and application of two RANK-specific antibodies with different biological activities.
    Chypre M; Seaman J; Cordeiro OG; Willen L; Knoop KA; Buchanan A; Sainson RC; Williams IR; Yagita H; Schneider P; Mueller CG
    Immunol Lett; 2016 Mar; 171():5-14. PubMed ID: 26773232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice.
    Wang B; Zhuang L; Fujisawa H; Shinder GA; Feliciani C; Shivji GM; Suzuki H; Amerio P; Toto P; Sauder DN
    J Immunol; 1999 Jan; 162(1):277-83. PubMed ID: 9886396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor activator for nuclear factor-κB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis.
    Boopalan T; Arumugam A; Parada J; Saltzstein E; Lakshmanaswamy R
    Cancer Sci; 2015 Jan; 106(1):25-33. PubMed ID: 25412610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive and inducible expression of interleukin-6 by Langerhans cells and lymph node dendritic cells.
    Cumberbatch M; Dearman RJ; Kimber I
    Immunology; 1996 Apr; 87(4):513-8. PubMed ID: 8675203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.
    Bharti AC; Takada Y; Aggarwal BB
    J Immunol; 2004 May; 172(10):5940-7. PubMed ID: 15128775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation.
    Ock S; Ahn J; Lee SH; Park H; Son JW; Oh JG; Yang DK; Lee WS; Kim HS; Rho J; Oh GT; Abel ED; Park WJ; Min JK; Kim J
    Cardiovasc Res; 2012 Apr; 94(1):105-14. PubMed ID: 22298642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
    Zhang Z; Jimi E; Bothwell AL
    J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-RANKing the Threat of HSV-1: RANKL Upregulates MHC-Class-I-Restricted Anti-Viral Immunity in Herpes Simplex Virus Infection.
    Finsterbusch K; Piguet V
    J Invest Dermatol; 2015 Nov; 135(11):2565-2567. PubMed ID: 26548487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor activator for NF-κB ligand in acute myeloid leukemia: expression, function, and modulation of NK cell immunosurveillance.
    Schmiedel BJ; Nuebling T; Steinbacher J; Malinovska A; Wende CM; Azuma M; Schneider P; Grosse-Hovest L; Salih HR
    J Immunol; 2013 Jan; 190(2):821-31. PubMed ID: 23241893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANKL/RANK-beyond bones.
    Hanada R; Hanada T; Sigl V; Schramek D; Penninger JM
    J Mol Med (Berl); 2011 Jul; 89(7):647-56. PubMed ID: 21445556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.